Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
about
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP studyPulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib.The impact of MRI sequence on tumour staging and gross tumour volume delineation in squamous cell carcinoma of the anal canal.Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
P2860
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diffusion-weighted and multiph ...... etastatic renal cell carcinoma
@en
Diffusion-weighted and multiph ...... tastatic renal cell carcinoma.
@nl
type
label
Diffusion-weighted and multiph ...... etastatic renal cell carcinoma
@en
Diffusion-weighted and multiph ...... tastatic renal cell carcinoma.
@nl
prefLabel
Diffusion-weighted and multiph ...... etastatic renal cell carcinoma
@en
Diffusion-weighted and multiph ...... tastatic renal cell carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Diffusion-weighted and multiph ...... etastatic renal cell carcinoma
@en
P2093
M E Miquel
P D Wilson
S Chowdhury
P2860
P2888
P304
P356
10.1038/BJC.2013.790
P407
P577
2013-12-24T00:00:00Z